Cibus Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.77

-0.13 (-6.84%)

As of Aug 15, 10:41 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 78%

Hold 2 22%

Sell 0 0%

Price Target

Analyst Price Target +1,617.5% upside

Low Target $22.94

Average Target $30.40

High Target $39.68

Current Price $1.77

Current
$1.77

Target
$30.40

$22.94 $30.40 avg $39.68

Scenario Analysis

Bear Case

$22.94

1,196.0%

Low target

Base Case

$30.40

+1,617.5%

Avg target

Bull Case

$39.68

+2,141.8%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$4.19

-57.8% from high

52-Week Low

$1.09

+62.4% from low

Target vs 52W High

$30.40

+625.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%